{"id":156,"date":"2023-01-07T05:36:23","date_gmt":"2023-01-07T05:36:23","guid":{"rendered":"https:\/\/pharmatradz.com\/blog\/?p=156"},"modified":"2023-01-07T05:36:23","modified_gmt":"2023-01-07T05:36:23","slug":"how-can-generic-drug-manufacturers-capture-more-business-opportunities","status":"publish","type":"post","link":"https:\/\/pharmatradz.com\/blog\/how-can-generic-drug-manufacturers-capture-more-business-opportunities\/","title":{"rendered":"How can generic drug manufacturers capture more business opportunities?"},"content":{"rendered":"<p>The global generic drug market will continue to expand. Currently, penetration in Europe and other developed markets varies, but based on market trends, generic penetration in developed markets could be around 80-90% in a decade or so.<\/p>\n<div id=\"output-content\"><strong><span class=\"sw\">3<\/span> <span class=\"sw\">Ways<\/span> <span class=\"sw\">to<\/span> <span class=\"sw\">Succeed<\/span> <span class=\"sw\">in<\/span> <span class=\"sw\">the<\/span> <span class=\"sw\">Generic<\/span> <span class=\"sw\">Drug<\/span> <span class=\"sw\">Market<\/span><\/strong><\/div>\n<div><\/div>\n<div><strong>1. Gettting Bigger &amp; Better<\/strong><\/div>\n<div><\/div>\n<div id=\"copy_to_clipboard_box\">\n<div id=\"axnbtn\">To combat buy-side consolidation, manufacturers may take the tempting route of acquiring smaller competitors or merging with larger companies. Over the next few years, several large pharmaceutical companies may spin off their generic drug divisions, further opening up opportunities for M&amp;A activity.<\/div>\n<\/div>\n<div><\/div>\n<div><strong>2. <span style=\"font-size: inherit;\">Elimination of middlemen and vertical growth<\/span><\/strong><\/div>\n<div><strong><span style=\"font-size: inherit;\"><br \/>\n<\/span><\/strong>Both backward (distribution) and forward (drug manufacturing) integration are seen as viable strategies to give generic drug manufacturers more control. Having manufacturing capabilities for both active pharmaceutical ingredients (APIs) and finished drug products (FDFs) is common, and may become even more common in the future.<\/p>\n<p><strong>3. Concentrating on different generics<\/strong><\/p>\n<p>Nowadays, speed-to-market is everything, thus any procedure that shortens that time is appreciated.<\/p>\n<p>Manufacturers have the additional advantage of tailoring their product to the patient behaviours of a particular market by creating differentiated medications (often with enhancements in terms of dose form, formulation, dosing regimen, or mode of administration).<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The global generic drug market will continue to expand. Currently, penetration in Europe and other developed markets varies, but based on market trends, generic penetration in developed markets could be around 80-90% in a decade or so. 3 Ways to Succeed in the Generic Drug Market 1. Gettting Bigger &amp; Better To combat buy-side consolidation, &#8230; <a title=\"How can generic drug manufacturers capture more business opportunities?\" class=\"read-more\" href=\"https:\/\/pharmatradz.com\/blog\/how-can-generic-drug-manufacturers-capture-more-business-opportunities\/\" aria-label=\"Read more about How can generic drug manufacturers capture more business opportunities?\">Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","footnotes":""},"categories":[3],"tags":[],"class_list":{"0":"post-156","1":"post","2":"type-post","3":"status-publish","4":"format-standard","6":"category-pharma"},"_links":{"self":[{"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/posts\/156","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/comments?post=156"}],"version-history":[{"count":1,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/posts\/156\/revisions"}],"predecessor-version":[{"id":158,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/posts\/156\/revisions\/158"}],"wp:attachment":[{"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/media?parent=156"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/categories?post=156"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmatradz.com\/blog\/wp-json\/wp\/v2\/tags?post=156"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}